Barentz Acquires Indian Chemical Distributor Anshul Life Sciences

Barentz International, a global provider of specialty ingredient solutions, recently announced the acquisition of Anshul Life Sciences in India, a specialty chemical distributor focused on the regulated pharmaceutical, food and nutraceutical, and personal care markets.

With this acquisition, Barentz has established a life sciences distribution platform in India. It is expected to bring strategic growth opportunities in India and across the Asia Pacific region. Both companies are committed to ensuring a seamless transition and maintaining the highest standards of value-added services. Nagarajan Kailasam (CEO of Anshul Life Sciences) and the current team of Anshul Life Sciences will continue to manage the day-to-day business operations.

“We are very pleased to welcome Anshul Life Sciences to the Barentz Group,” commented Marc Duchene, CEO of Asia Pacific. "This acquisition solidifies our ambition to grow further in India, one of our key strategic markets, and across the Asia Pacific region. This acquisition benefits our customers and principals by providing a broader portfolio of high-quality pharmaceutical excipients and products and a deeper pool of expertise. We are delighted that Mr. Nagarajan will continue to lead the company. Together, we aim to enhance our offerings to better meet the needs of the dynamic Indian market and beyond."

Anshul Life Sciences CEO Nagarajan Kailasam added, "Barentz is highly aligned with the entrepreneurial spirit and ethical standards of the founding partners of Anshul Life Science. We are excited to join the Barentz family and begin our collaboration to capture the huge potential of the Indian market by providing more comprehensive solutions to customers and principals in the Indian market and beyond. We look forward to the future and growing international presence this strategic move will bring to Anshul Life Sciences."